Lifevantage Corp
LFVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000849146
In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 1 sale; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Lifevantage Corp changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 53 | 53 | 0 |
| Shares | 3.00M | 2.91M | −90.4K (−3.0%) |
| Value | $19.4M | $17.5M | −$1.89M (−9.8%) |
New holders (5)
Institutions that held Lifevantage Corp at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 10,170 | $61.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 597 | $3.58K | 0.00% |
| Global Retirement Partners, LLC | 286 | $1.60K | 0.00% |
| Crewe Advisors LLC | 143 | $858 | 0.00% |
| Farther Finance Advisors, LLC | 42 | $252 | 0.00% |
Sold out (5)
Institutions that held Lifevantage Corp at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Millennium Management LLC | 89,176 | $575.2K |
| Walleye Capital LLC | 20,069 | $129.4K |
| Susquehanna International Group, LLP | 13,038 | $84.1K |
| Simplex Trading, LLC | 7,398 | $47.0K |
| Legacy Financial Group LLC | 200 | $1.29K |